86 Short-Term Outcomes and Patient Perceptions After EMS Non-Transport During the COVID-19 Pandemic

por Toy, J., Bosson, N., Chang, A., Haase, D., Kipust, A., Korotzer, L., Warren, J., Kim, Y.S., Kazan, C., Gausche-Hill, M.
Publicado 2022

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC – AFNET 9

por Fabritz, Larissa, Connolly, D., Czarnecki, E., Dudek, D., Zlahoda-Huzior, A., Guasch, E., Haase, D., Huebner, T., Jolly, K., Kirchhof, P., Schotten, Ulrich, Zapf, Antonia, Schnabel, Renate B.
Publicado 2022

Smartphone and wearable detected atrial arrhythmias in Older Adults: Results of a fully digital European Case finding study

por Fabritz, L, Connolly, D L, Czarnecki, E, Dudek, D, Guasch, E, Haase, D, Huebner, T, Zlahoda-Huzior, A, Jolly, K, Kirchhof, P, Obergassel, J, Schotten, U, Vettorazzi, E, Winkelmann, S J, Zapf, A, Schnabel, R B
Publicado 2022

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

por Platzbecker, U, Braulke, F, Kündgen, A, Götze, K, Bug, G, Schönefeldt, C, Shirneshan, K, Röllig, C, Bornhäuser, M, Naumann, R, Neesen, J, Giagounidis, A, Hofmann, W-K, Ehninger, G, Germing, U, Haase, D, Wermke, M
Publicado 2013

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

por Schlenk, R. F., Weber, D., Herr, W., Wulf, G., Salih, H. R., Derigs, H. G., Kuendgen, A., Ringhoffer, M., Hertenstein, B., Martens, U. M., Grießhammer, M., Bernhard, H., Krauter, J., Girschikofsky, M., Wolf, D., Lange, E., Westermann, J., Koller, E., Kremers, S., Wattad, M., Heuser, M., Thol, F., Göhring, G., Haase, D., Teleanu, V., Gaidzik, V., Benner, A., Döhner, K., Ganser, A., Paschka, P., Döhner, H.
Publicado 2019

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

por Kuendgen, A., Nomdedeu, M., Tuechler, H., Garcia-Manero, G., Komrokji, R. S., Sekeres, M. A., Della Porta, M. G., Cazzola, M., DeZern, A. E., Roboz, G. J., Steensma, D. P., Van de Loosdrecht, A. A., Schlenk, R. F., Grau, J., Calvo, X., Blum, S., Pereira, A., Valent, P., Costa, D., Giagounidis, A., Xicoy, B., Döhner, H., Platzbecker, U., Pedro, C., Lübbert, M., Oiartzabal, I., Díez-Campelo, M., Cedena, M. T., Machherndl-Spandl, S., López-Pavía, M., Baldus, C. D., Martinez-de-Sola, M., Stauder, R., Merchan, B., List, A., Ganster, C., Schroeder, T., Voso, M. T., Pfeilstöcker, M., Sill, H., Hildebrandt, B., Esteve, J., Nomdedeu, B., Cobo, F., Haas, R., Sole, F., Germing, U., Greenberg, P. L., Haase, D., Sanz, G.
Publicado 2020